PhRMA Lobby Spend Grows to $15.5M in the First Half of 2018

July 24, 2018

As the pharmaceutical industry faces potential pricing reform and continued criticism from patient advocates and members of Congress, the industry's top trade group spent $15.5 million lobbying in the first half, an 11.5% increase compared with the same period last year. Read More

AHIP: Rebates Not Driving Rise In Drug Pricing

July 24, 2018

America's Health Insurance Plans (AHIP) is fighting back against recent claims that drug rebates have been the primary driver of the rising cost of prescriptions, releasing their own report Friday about the impact of the discounts. Read More